Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (261-270 of 288) with videos related to

Pageof 29
Sort By:
Annals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.
Arthritis and Rheumatism|February 13, 2013
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitisMaria Apel, Steffen Uebe, John Bowes, et al.
Annals of the Rheumatic Diseases|February 12, 2016
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysisAlexandre Sepriano, Robert Landewé, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic ArthritisLaura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
Nature Genetics|October 19, 2010
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasisUlrike Hüffmeier, Steffen Uebe, Arif B Ekici, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Therapeutic Advances in Musculoskeletal Disease|September 11, 2023
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritisOliver FitzGerald, Frank Behrens, Anne Barton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2022
Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction ModelingMehreen Soomro, Michael Stadler, Nick Dand, et al.
Arthritis Care & Research|January 29, 2014
Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing toolsLaura C Coates, Jessica Walsh, Muhammad Haroon, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, et al.
Pageof 29

Showing results (261-270 of 288) with videos related to

Sort By:
Pageof 29
Annals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.
Arthritis and Rheumatism|February 13, 2013
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitisMaria Apel, Steffen Uebe, John Bowes, et al.
Annals of the Rheumatic Diseases|February 12, 2016
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysisAlexandre Sepriano, Robert Landewé, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic ArthritisLaura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
Nature Genetics|October 19, 2010
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasisUlrike Hüffmeier, Steffen Uebe, Arif B Ekici, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Therapeutic Advances in Musculoskeletal Disease|September 11, 2023
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritisOliver FitzGerald, Frank Behrens, Anne Barton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2022
Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction ModelingMehreen Soomro, Michael Stadler, Nick Dand, et al.
Arthritis Care & Research|January 29, 2014
Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing toolsLaura C Coates, Jessica Walsh, Muhammad Haroon, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, et al.
Pageof 29